Companies Cryptocurrencies
Vaxcyte Inc
Vaxcyte Inc
Exchange: NasdaqGS
IPO Date: 12/06/2020
CEO: Mr. Grant E. Pickering
Biotechnology Healthcare đź”—
  • PCVX
  • 24.54
  • 1431020672
    market cap
  • 1.0100002
If you bought

shares of Vaxcyte Inc (PCVX) on
You would have made
Old Price $12 Current Price $12

Vaxcyte, Inc. is a vaccine company. The Company is developing vaccines to prevent some common and deadly infectious diseases. The Company’s cell-free protein synthesis platform enables to design and produce protein carriers and antigens, the critical building blocks of vaccines. The Company’s pipeline includes pneumococcal conjugate vaccine (PCV). The Company’s lead vaccine candidate is, VAX-24, is a 24-valent investigational PCV. The Company’s candidate include VAX-XP, leverages scalable and modular platform and builds on the technical concept established by VAX-24; VAX-A1 for Group A Strep and VAX-PG for periodontitis.

Address: 353 Hatch Dr Foster City CALIFORNIA 94404

Stay updated.